BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23810423)

  • 1. Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum.
    Rathi B; Singh AK; Kishan R; Singh N; Latha N; Srinivasan S; Pandey KC; Tiwari HK; Singh BK
    Bioorg Med Chem; 2013 Sep; 21(17):5503-9. PubMed ID: 23810423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
    Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
    J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite.
    Singh AK; Rajendran V; Pant A; Ghosh PC; Singh N; Latha N; Garg S; Pandey KC; Singh BK; Rathi B
    Bioorg Med Chem; 2015 Apr; 23(8):1817-27. PubMed ID: 25766631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.
    Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M
    ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falcipain-2 inhibition by suramin and suramin analogues.
    Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
    Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
    Muthas D; Nöteberg D; Sabnis YA; Hamelink E; Vrang L; Samuelsson B; Karlén A; Hallberg A
    Bioorg Med Chem; 2005 Sep; 13(18):5371-90. PubMed ID: 16054370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
    Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
    J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity.
    Khanye SD; Smith GS; Lategan C; Smith PJ; Gut J; Rosenthal PJ; Chibale K
    J Inorg Biochem; 2010 Oct; 104(10):1079-83. PubMed ID: 20621360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain.
    Ettari R; Zappalà M; Micale N; Schirmeister T; Gelhaus C; Leippe M; Evers A; Grasso S
    Eur J Med Chem; 2010 Jul; 45(7):3228-33. PubMed ID: 20434817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
    Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
    J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
    Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
    Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
    Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
    Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives.
    Liu Y; Cui K; Lu W; Luo W; Wang J; Huang J; Guo C
    Molecules; 2011 May; 16(6):4527-38. PubMed ID: 21629181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent amino acid residues in the S2 pocket of falcipain-3 determine its specificity for P2 residues in substrates.
    Kolla VK; Prasad R; Sayyad Z; Atul ; Shah AY; Allanki AD; Navale R; Singhal N; Tanneru N; Sudhakar R; Venkatesan V; Deshmukh MV; Sijwali PS
    Mol Biochem Parasitol; 2015 Aug; 202(2):11-22. PubMed ID: 26439304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum.
    Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
    Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
    J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.